• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证瑞典患者登记处的食管癌手术数据。

Validation of oesophageal cancer surgery data in the Swedish Patient Registry.

机构信息

Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

出版信息

Acta Oncol. 2012 Jan;51(1):65-8. doi: 10.3109/0284186X.2011.633932.

DOI:10.3109/0284186X.2011.633932
PMID:22150167
Abstract

BACKGROUND

The Swedish Patient Registry provides data about diagnoses and surgical procedures for research purposes. There are, however, almost no validation studies of the data on surgical procedures, and none of oesophageal cancer surgery.

MATERIAL AND METHODS

This was a validation study of the accuracy of codes representing oesophageal cancer resection, surgical approach and oesophageal substitute in the Swedish Patient Registry during the period 1987-2005. The registered data were compared with a thorough review of the corresponding operation charts collected from medical records.

RESULTS

Among 1358 patients with a code representing oesophageal resection in the Patient Registry, the positive predictive value was 99.6%. The dominant surgical procedures in terms of surgical approach (transthoracic) and type of oesophageal substitute (gastric conduit) had positive predictive values of 99.8% and 99.4%, respectively. The more rare procedures with regards to approach (transhiatal) and substitute (bowel) had lower positive predictive values of 68.8% and 68.5%, respectively.

CONCLUSION

The high accuracy of the data regarding oesophageal cancer resection in the Swedish Patient Registry stresses its appropriateness for research purposes.

摘要

背景

瑞典患者注册中心提供了有关诊断和手术程序的数据,用于研究目的。然而,几乎没有关于手术程序数据的验证研究,也没有关于食管癌手术的验证研究。

材料和方法

这是一项关于瑞典患者注册中心在 1987 年至 2005 年期间的食管癌切除术、手术入路和食管替代物代码准确性的验证研究。将登记数据与从病历中收集的相应手术图表进行详细审查进行比较。

结果

在患者注册中心中,有 1358 例代码代表食管切除术的患者中,阳性预测值为 99.6%。在手术入路(经胸)和食管替代物(胃管)方面,主要的手术方法的阳性预测值分别为 99.8%和 99.4%。在入路(经食管裂孔)和替代物(肠道)方面,较为罕见的手术方法的阳性预测值分别为 68.8%和 68.5%。

结论

瑞典患者注册中心中食管癌切除术数据的高度准确性强调了其在研究中的适当性。

相似文献

1
Validation of oesophageal cancer surgery data in the Swedish Patient Registry.验证瑞典患者登记处的食管癌手术数据。
Acta Oncol. 2012 Jan;51(1):65-8. doi: 10.3109/0284186X.2011.633932.
2
The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia.手术量对食管癌和贲门癌患者医院死亡率及5年生存率的影响。
Anticancer Res. 2005 Jan-Feb;25(1B):419-24.
3
Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.在瑞典进行的一项全国性巢式病例对照研究中,口腔疾病与食管和胃癌风险的关系。
Eur J Cancer. 2011 Sep;47(14):2128-32. doi: 10.1016/j.ejca.2011.03.012. Epub 2011 Apr 12.
4
Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden.食管癌切除术后并发症的危险因素:瑞典一项基于人群的前瞻性研究。
Ann Surg. 2006 Feb;243(2):204-11. doi: 10.1097/01.sla.0000197698.17794.eb.
5
Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences.食管癌和贲门癌的发病率。随时间的变化及地域差异。
Acta Oncol. 2007;46(8):1070-4. doi: 10.1080/02841860701403046.
6
Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.在瑞典一项全国性研究中,影响食管癌和贲门癌长期生存的患者人口统计学和生活方式因素
Eur J Cancer. 2008 Jul;44(11):1566-71. doi: 10.1016/j.ejca.2008.04.002. Epub 2008 Apr 22.
7
Malnutrition after oesophageal cancer surgery in Sweden.瑞典食管癌手术后的营养不良
Br J Surg. 2007 Dec;94(12):1496-500. doi: 10.1002/bjs.5881.
8
New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.食管癌淋巴转移的新见解及其对手术切除范围的影响。
Best Pract Res Clin Gastroenterol. 2006;20(5):893-906. doi: 10.1016/j.bpg.2006.03.010.
9
Impact of co-morbidity on mortality after oesophageal cancer surgery.合并症对食管癌手术后死亡率的影响。
Br J Surg. 2015 Aug;102(9):1097-105. doi: 10.1002/bjs.9854. Epub 2015 Jun 8.
10
The influence of needle catheter jejunostomy on weight development after oesophageal cancer surgery in a population-based study.一项基于人群的研究:经皮穿刺空肠造口术对食管癌手术后体重变化的影响
Eur J Surg Oncol. 2007 Aug;33(6):713-7. doi: 10.1016/j.ejso.2007.01.011. Epub 2007 Feb 22.

引用本文的文献

1
External review of procedure codes for intensive care, mechanical ventilation and extracorporeal membrane oxygenation for critically ill COVID-19 patients in the Swedish inpatient register: A nationwide observational cohort study.瑞典住院患者登记册中危重症COVID-19患者重症监护、机械通气和体外膜肺氧合程序代码的外部审查:一项全国性观察性队列研究。
Eur J Anaesthesiol Intensive Care. 2025 Feb 17;4(2):e0071. doi: 10.1097/EA9.0000000000000071. eCollection 2025 Apr.
2
Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register.瑞典国家患者登记处的诊断准确性:一项包括门诊登记处诊断的综述。
Eur J Epidemiol. 2025 Mar 27. doi: 10.1007/s10654-025-01221-0.
3
Surgeon age in relation to patients' long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study.
胃腺癌患者行胃切除术后与外科医生年龄相关的长期生存:全国基于人群的队列研究。
BJS Open. 2024 Mar 1;8(2). doi: 10.1093/bjsopen/zrae015.
4
Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.阿司匹林或他汀类药物的使用与食管癌手术后生存的关系:一项基于人群的队列研究。
BMC Cancer. 2023 Apr 25;23(1):375. doi: 10.1186/s12885-023-10819-0.
5
Impact of Age on the Treatment and Survival in Esophagogastric Cancer.年龄对食管胃结合部癌治疗和生存的影响。
Ann Surg Oncol. 2023 May;30(5):2716-2725. doi: 10.1245/s10434-022-13052-4. Epub 2023 Jan 17.
6
Health-related quality of life 15 years after oesophageal cancer surgery: a prospective nationwide cohort study.食管癌手术后 15 年的健康相关生活质量:一项前瞻性全国队列研究。
J Cancer Surviv. 2023 Jun;17(3):815-825. doi: 10.1007/s11764-022-01257-1. Epub 2022 Oct 11.
7
Body Mass Index-Adjusted Weight Loss Grading System and Cancer-Related Fatigue in Survivors 1 Year After Esophageal Cancer Surgery.食管癌手术后1年幸存者的体重指数调整后体重减轻分级系统与癌症相关疲劳
Ann Surg Oncol. 2022 Apr 1;29(7):4502-10. doi: 10.1245/s10434-022-11633-x.
8
Life Expectancy in Survivors of Esophageal Cancer Compared with the Background Population.食管癌幸存者与背景人群的预期寿命比较。
Ann Surg Oncol. 2022 May;29(5):2805-2811. doi: 10.1245/s10434-022-11416-4. Epub 2022 Feb 21.
9
Cancer-Related Fatigue After Esophageal Cancer Surgery: Impact of Postoperative Complications.食管癌手术后与癌症相关的疲劳:术后并发症的影响。
Ann Surg Oncol. 2022 May;29(5):2842-2851. doi: 10.1245/s10434-021-11049-z. Epub 2021 Nov 23.
10
Impact of co-morbidity on reoperation or death within 90 days of surgery for oesophageal cancer.合并症对食管癌术后 90 天内再次手术或死亡的影响。
BJS Open. 2021 Jan 8;5(1). doi: 10.1093/bjsopen/zraa035.